Axitinib

Axitinib, also known as AG013736, is an orally bioavailable tyrosine kinase inhibitor. Axitinib exerts anti-angiogenic effects by inhibiting the pro-angiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF).
Supplier Alfa Cytology
Product # BC0474
Pricing 25.0 mg, 50.0 mg, 100.0 mg, 500.0 mg, 1.0 g, inquire
Feedback